Background In the absence of clinical trial data, large post-marketing observational studies
are essential to evaluate the safety and effectiveness of medications during pregnancy. We …

Background: Prior studies suggest that women who use antidepressants during pregnancy
have an increased risk for preeclampsia, yet the comparative safety of specific …

Despite intense investigation, mechanisms that facilitate the emergence of the pre-eclampsia
phenotype in women are still unknown. Placental hypoxia, hypertension, proteinuria and …

OBJECTIVE: To characterize the 20 most common prescription medications and the 10 most
common prescription medications classified in the former US Food and Drug Administration …

Background Whether the use of selective serotonin-reuptake inhibitors (SSRIs) and other
antidepressants during pregnancy is associated with an increased risk of congenital cardiac …

Corticosteroids are administered in pregnancy for their immunosuppressive and antiinflammatory
effects. 1 They are used to treat symptoms of autoimmune conditions, because many …

A previous study suggested an increased risk of preeclampsia among women treated with
selective serotonin reuptake inhibitors (SSRIs). Using population-based health-care utilization …

Purpose The aim of this study is to assess the validity of preeclampsia, congenital cardiac
malformations, and persistent pulmonary hypertension of the newborn (PPHN) diagnoses in …

Importance The association between selective serotonin reuptake inhibitor (SSRI) antidepressant
use during pregnancy and risk of persistent pulmonary hypertension of the newborn (…

Objective To determine whether use of serotonin or non-serotonin reuptake inhibitors near
to delivery is associated with postpartum hemorrhage. Design Cohort study. Setting 2000-07 …